|
DGAP-Ad-hoc: Beiersdorf Aktiengesellschaft / Key word(s): Personnel Change in the Chair of the Executive Board
At today's meeting, the Supervisory Board of Beiersdorf Aktiengesellschaft, Hamburg, and the Chairman of the Executive Board, Stefan De Loecker, reached an amicable agreement that he will resign from the Executive Board as of 30 June 2021. The Supervisory Board appointed Vincent Warnery, currently responsible in the Executive Board for the "Pharmacy & Selective" as well as for the North America business, as Chairman of the Executive Board of the company with effect from 1 May 2021. The Supervisory Board also extended Mr. Warnery's appointment for a further five years until 31 January 2027. Contact: Dr. Jens Geißler Head of Investor Relations Tel.: +49 (40) 4909 5000 Fax: +49 (40) 4909 18 5000 Anke Schmidt Head of Corporate Communications Tel.: +49 (40) 4909 2001 Fax: +49 (40) 4909 2516
27-Apr-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Beiersdorf Aktiengesellschaft |
| Unnastraße 48 | |
| 20245 Hamburg | |
| Germany | |
| Phone: | +49 (0)40 4909-0 |
| Fax: | +49 (0)40 4909-34 34 |
| E-mail: | kontakt@Beiersdorf.com |
| Internet: | www.Beiersdorf.com |
| ISIN: | DE0005200000 |
| WKN: | 520000 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Dusseldorf, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1189537 |
| End of Announcement | DGAP News Service |
|
|
1189537 27-Apr-2021 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
